{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:45:49Z","timestamp":1740163549635,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fluctuations of the sex steroids during the menstrual cycle might significantly influence hemostasis. This association, derived from a number of the observations on healthy women, is yet to be described in females affected by bleeding disorders. The aim of the current study was to assess the changes in hemostatic variables in women with vWD during two phases of the menstrual cycle (follicular and luteal) and to compare it with healthy controls. The study group included 12 vWD-affected females with regular menstrual cycle, with none of them being prescribed any hormonal treatment. The control group consisted of 102 healthy females, matched for age and BMI. Within the vWD group FVIII and FX were both significantly higher during follicular phase than in luteal phase (p\u2009=\u20090.013 and p\u2009=\u20090.033 respectively). AT, FII, FVII and FX were higher in women with vWD, compared with controls during both phases of the menstrual cycle (p\u2009&lt;\u20090.0005, p\u2009&lt;\u20090.0005, p\u2009=\u20090.001 and p\u2009&lt;\u20090.0005). In women with vWD, lag time and time to peak were prolonged during both phases of the menstrual cycle(p\u2009&lt;\u20090.0005), while peak thrombin concentration was reduced (p\u2009=\u20090.003 and p\u2009=\u20090.002 during follicular and luteal phase respectively) compared to healthy peers. Lower levels of FVIII and FX during luteal phase may predispose women to the development of the menorrhagia - common complication of vWD. Women with vWD need more time to reach the peak thrombin concentration, while the latter still remains less than in healthy women. Higher levels of AT in vWD-affected females, compared to controls, may also contribute to the existing bleeding tendency in this cohort.<\/jats:p>","DOI":"10.1038\/s41598-018-35897-0","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T15:27:55Z","timestamp":1543246075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Thrombin generation during a regular menstrual cycle in women with von Willebrand disease"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-0270","authenticated-orcid":false,"given":"Igor","family":"Govorov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Bremme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas L.","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margareta","family":"Holmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Komlichenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roza","family":"Chaireti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Mints","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"35897_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","volume":"8","author":"M Bowman","year":"2010","unstructured":"Bowman, M., Hopman, W. M., Rapson, D., Lillicrap, D. & James, P. The prevalence of symptomatic von Willebrand disease in primary care practice. J. Thromb. Haemost. 8, 213\u2013216, https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03661.x (2010).","journal-title":"J. Thromb. Haemost."},{"key":"35897_CR2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","volume":"69","author":"F Rodeghiero","year":"1987","unstructured":"Rodeghiero, F., Castaman, G. & Dini, E. Epidemiological investigation of the prevalence of von Willebrand\u2019s disease. Blood 69, 454\u2013459 (1987).","journal-title":"Blood"},{"key":"35897_CR3","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","volume":"4","author":"JE Sadler","year":"2006","unstructured":"Sadler, J. E. et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J. Thromb. Haemost. 4, 2103\u20132114, https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02146.x (2006).","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl 1","key":"35897_CR4","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S0049-3848(09)70151-3","volume":"124","author":"AH James","year":"2009","unstructured":"James, A. H. Von Willebrand disease in women: awareness and diagnosis. Thromb. Res. 124(Suppl 1), S7\u201310, https:\/\/doi.org\/10.1016\/S0049-3848(09)70151-3 (2009).","journal-title":"Thromb. Res."},{"key":"35897_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000077820","volume":"33","author":"H Ikarugi","year":"2003","unstructured":"Ikarugi, H. et al. High intensity exercise enhances platelet reactivity to shear stress and coagulation during and after exercise. Pathophysiol Haemost Thromb 33, 127\u2013133, https:\/\/doi.org\/10.1159\/000077820 (2003).","journal-title":"Pathophysiol Haemost Thromb"},{"key":"35897_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1055\/s-0029-1222605","volume":"35","author":"G Lippi","year":"2009","unstructured":"Lippi, G. & Maffulli, N. Biological influence of physical exercise on hemostasis. Semin Thromb Hemost 35, 269\u2013276, https:\/\/doi.org\/10.1055\/s-0029-1222605 (2009).","journal-title":"Semin Thromb Hemost"},{"key":"35897_CR7","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1055\/s-0037-1614855","volume":"82","author":"RA Kadir","year":"1999","unstructured":"Kadir, R. A., Economides, D. L., Sabin, C. A., Owens, D. & Lee, C. A. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb. Haemost. 82, 1456\u20131461 (1999).","journal-title":"Thromb. Haemost."},{"key":"35897_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1160\/TH11-07-0481","volume":"107","author":"HM Knol","year":"2012","unstructured":"Knol, H. M., Kemperman, R. F., Kluin-Nelemans, H. C., Mulder, A. B. & Meijer, K. Haemostatic variables during normal menstrual cycle. A systematic review. Thromb. Haemost. 107, 22\u201329, https:\/\/doi.org\/10.1160\/TH11-07-0481 (2012).","journal-title":"Thromb. Haemost."},{"key":"35897_CR9","doi-asserted-by":"publisher","first-page":"009","DOI":"10.1055\/s-0038-1661594","volume":"56","author":"H Hemker","year":"1986","unstructured":"Hemker, H., Willems, G. & Beguin, S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thrombosis and haemostasis 56, 009\u2013017 (1986).","journal-title":"Thrombosis and haemostasis"},{"key":"35897_CR10","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/humrep\/det092","volume":"28","author":"R Chaireti","year":"2013","unstructured":"Chaireti, R., Gustafsson, K. M., Bystrom, B., Bremme, K. & Lindahl, T. L. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle. Hum. Reprod. 28, 1846\u20131852, https:\/\/doi.org\/10.1093\/humrep\/det092 (2013).","journal-title":"Hum. Reprod."},{"key":"35897_CR11","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3324\/haematol.11460","volume":"92","author":"L Rugeri","year":"2007","unstructured":"Rugeri, L. et al. Thrombin-generating capacity in patients with von Willebrand\u2019s disease. Haematologica 92, 1639\u20131646, https:\/\/doi.org\/10.3324\/haematol.11460 (2007).","journal-title":"Haematologica"},{"key":"35897_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000214194","volume":"6","author":"G Cederblad","year":"1977","unstructured":"Cederblad, G., Hahn, L., Korsan-Bengtsen, K., Pehrsson, N. & Rybo, G. Variations in blood coagulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle. Pathophysiol. Haemost. Thromb. 6, 294\u2013302 (1977).","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"35897_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4314\/eamj.v79i4.8874","volume":"79","author":"DV Dapper","year":"2002","unstructured":"Dapper, D. V. & Didia, B. C. Haemorheological changes during the menstrual cycle. East Afr. Med. J. 79, 181\u2013183 (2002).","journal-title":"East Afr. Med. J."},{"key":"35897_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/107602960501100308","volume":"11","author":"SC Koh","year":"2005","unstructured":"Koh, S. C., Prasad, R. & Fong, Y. Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycle. Clinical and applied thrombosis\/hemostasis 11, 295\u2013301 (2005).","journal-title":"Clinical and applied thrombosis\/hemostasis"},{"key":"35897_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1055\/s-2007-1009258","volume":"21","author":"AM Lebech","year":"1989","unstructured":"Lebech, A. M. & Kjaer, A. Lipid metabolism and coagulation during the normal menstrual cycle. Horm. Metab. Res. 21, 445\u2013448, https:\/\/doi.org\/10.1055\/s-2007-1009258 (1989).","journal-title":"Horm. Metab. Res."},{"key":"35897_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1055\/s-0038-1648383","volume":"67","author":"M Blomback","year":"1992","unstructured":"Blomback, M., Eneroth, P., Landgren, B. M., Lagerstrom, M. & Anderson, O. On the intraindividual and gender variability of haemostatic components. Thromb. Haemost. 67, 70\u201375 (1992).","journal-title":"Thromb. Haemost."},{"key":"35897_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1055\/s-0038-1655915","volume":"77","author":"M Blomback","year":"1997","unstructured":"Blomback, M., Landgren, B. M., Stiernholm, Y. & Andersson, O. The effect of progesterone on the haemostatic mechanism. Thromb. Haemost. 77, 105\u2013108 (1997).","journal-title":"Thromb. Haemost."},{"key":"35897_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/s-0037-1612925","volume":"85","author":"PT \u00d6nundarson","year":"2001","unstructured":"\u00d6nundarson, P. T., Gudmundsdottir, B. R., Arnfinnsdottir, A. V., Kjeld, M. & \u00d3lafsson, \u00d6. Von Willebrand factor does not vary during normal menstrual cycle. Thromb. Haemost. 85, 183\u2013184 (2001).","journal-title":"Thromb. Haemost."},{"key":"35897_CR19","first-page":"PI78","volume":"8","author":"MA Repina","year":"2002","unstructured":"Repina, M. A., Korzo, T. M. & Zinina, T. A. Effect of hormone replacement therapy with femoston on hemostasis in peri- and postmenopausal women. Med. Sci. Monit. 8, PI78\u201384 (2002).","journal-title":"Med. Sci. Monit."},{"key":"35897_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/03009738909178559","volume":"94","author":"A Siegbahn","year":"1989","unstructured":"Siegbahn, A., Odlind, V., Hedner, U. & Venge, P. Coagulation and fibrinolysis during the normal menstrual cycle. Ups. J. Med. Sci. 94, 137\u2013152 (1989).","journal-title":"Ups. J. Med. Sci."},{"key":"35897_CR21","first-page":"1093","volume":"302","author":"T Mandalaki","year":"1980","unstructured":"Mandalaki, T., Louizou, C., Dimitriadou, C. & Symeonidis, P. Variations in factor VIII during the menstrual cycle in normal women. N. Engl. J. Med. 302, 1093\u20131094 (1980).","journal-title":"N. Engl. J. Med."},{"key":"35897_CR22","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1055\/s-0037-1613140","volume":"87","author":"CH Miller","year":"2002","unstructured":"Miller, C. H., Dilley, A. B., Drews, C., Richardson, L. & Evatt, B. Changes in von Willebrand factor and factor VIII levels during the menstrual cycle. Thromb. Haemost. 87, 1082\u20131083 (2002).","journal-title":"Thromb. Haemost."},{"key":"35897_CR23","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.3892\/etm.2016.3144","volume":"11","author":"I Govorov","year":"2016","unstructured":"Govorov, I. et al. Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand\u2019s disease. Exp. Ther. Med. 11, 1923\u20131929, https:\/\/doi.org\/10.3892\/etm.2016.3144 (2016).","journal-title":"Exp. Ther. Med."},{"key":"35897_CR24","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rk, I. & Olson, S. T. In Chemistry and biology of serpins 17\u201333 (Springer, 1997).","DOI":"10.1007\/978-1-4615-5391-5_3"},{"key":"35897_CR25","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/j.1538-7836.2005.01249.x","volume":"3","author":"K Brummel-Ziedins","year":"2005","unstructured":"Brummel-Ziedins, K., Vossen, C. Y., Rosendaal, F. R., Umezaki, K. & Mann, K. G. The plasma hemostatic proteome: thrombin generation in healthy individuals. J. Thromb. Haemost. 3, 1472\u20131481, https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01249.x (2005).","journal-title":"J. Thromb. Haemost."},{"key":"35897_CR26","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1210\/jc.2004-0598","volume":"89","author":"EG Giardina","year":"2004","unstructured":"Giardina, E. G., Chen, H. J., Sciacca, R. R. & Rabbani, L. E. Dynamic variability of hemostatic and fibrinolytic factors in young women. J. Clin. Endocrinol. Metab. 89, 6179\u20136184, https:\/\/doi.org\/10.1210\/jc.2004-0598 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"35897_CR27","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1111\/jth.12012","volume":"10","author":"R Loeffen","year":"2012","unstructured":"Loeffen, R. et al. Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method. J Thromb Haemost 10, 2544\u20132554, https:\/\/doi.org\/10.1111\/jth.12012 (2012).","journal-title":"J Thromb Haemost"},{"key":"35897_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1046\/j.1537-2995.2001.41010056.x","volume":"41","author":"A Moeller","year":"2001","unstructured":"Moeller, A., Weippert-Kretschmer, M., Prinz, H. & Kretschmer, V. Influence of ABO blood groups on primary hemostasis. Transfusion 41, 56\u201360 (2001).","journal-title":"Transfusion"},{"key":"35897_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1365-3148.2001.00315.x","volume":"11","author":"J O\u2019donnell","year":"2001","unstructured":"O\u2019donnell, J. & Laffan, M. The relationship between ABO histo\u2010blood group, factor VIII and von Willebrand factor. Transfusion Medicine 11, 343\u2013351 (2001).","journal-title":"Transfusion Medicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35897-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35897-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35897-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T12:10:15Z","timestamp":1671624615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35897-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35897"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35897-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"10 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17467"}}